CoChat

A novel long‐acting glucose‐dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents

Open access
Tatarkiewicz, K., Hargrove, D. M., Jodka, C. M., Gedulin, B. R., Smith, P. A., Hoyt, J. A., Lwin, A., Collins, L., Mamedova, L., Levy, O. E., D'Souza, L., Janssen, S., Srivastava, V., Ghosh, S. S., Parkes, D. G. · 2014 · Diabetes, Obesity and Metabolism
Cited by 32

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Aim: Glucose‐dependent insulinotropic peptide ( GIP ) is an incretin hormone that is released from intestinal K cells in response to nutrient ingestion. We aimed to investigate the therapeutic potential of the novel N‐ and C‐terminally modified GIP analogue AC163794 . Methods: AC163794 was synthesized by solid‐phase peptide synthesis. Design involved the substitution of the C‐terminus tail region of the dipeptidyl peptidase IV ( DPP‐IV )‐resistant GIP analogue [ d ‐Ala 2 ] GIP (1–42) with the unique nine amino acid tail region of exenatide. The functional activity and binding of AC163794 to the GIP receptor were evaluated in RIN‐m5F β‐cells. In vitro metabolic stability was tested in human plasma and kidney membrane preparations. Acute insulinotropic effects were investigated in isolated mouse islets and during an intravenous glucose tolerance test in normal and diabetic Zucker fatty diabetic ( ZDF ) rats. The biological actions of AC163794 were comprehensively assessed in normal, ob/ob and high‐fat‐fed streptozotocin ( STZ )‐induced diabetic mice. Acute glucoregulatory effects of AC163794 were tested in diet‐induced obese mice treated subchronically with AC3174 , the exendatide analogue [Leu 14 ] exenatide. Human GIP or [ d ‐Ala 2 ] GIP (1–42) were used for comparison. Results: AC163794 exhibited nanomolar functional GIP receptor potency in vitro similar to GIP and [ d ‐Ala 2 ] GIP (1–42). AC163794 was metabolically more stable in vitro and displayed longer duration of insulinotropic action in vivo versus GIP and [ d ‐Ala 2 ] GIP (1–42). In diabetic mice, AC163794 improved HbA1c through enhanced insulinotropic action, partial restoration of pancreatic insulin content and improved insulin sensitivity with no adverse effects on fat storage and metabolism. AC163794 provided additional baseline glucose‐lowering when injected to mice treated with AC3174 . Conclusions: These studies support the potential use of a novel GIP analogue AC163794 for the treatment of type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12181

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

Metadata

Authors
Tatarkiewicz, K., Hargrove, D. M., Jodka, C. M., Gedulin, B. R., Smith, P. A., Hoyt, J. A., Lwin, A., Collins, L., Mamedova, L., Levy, O. E., D'Souza, L., Janssen, S., Srivastava, V., Ghosh, S. S., & Parkes, D. G.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2013-08-19
Volume
16
Issue
1
Pages
75-85
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2123015247
Cited by
32
References
11
FWCI
3.07
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.